Skip to content

Efficacy and mechanisms of internet-delivered mindfulness-based cognitive therapy for Adjustment Disorder: A randomized controlled trial.

Paweł Holas, Jan Wardęszkiewicz, Malgorzata Grochowska, Stefan G Hofmann

Journal of Anxiety Disorders July 1, 2026 DOI: 10.1016/j.janxdis.2026.103173 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial Peer reviewed
Sample size 301
Population Adults meeting ICD-11 criteria for Adjustment Disorder during the COVID-19 pandemic
Interventions internet-delivered Mindfulness-Based Cognitive Therapy internet-delivered progressive muscle relaxation
Duration 4-week intervention, 1-month follow-up
Topics Meditation
Keywords Adjustment disorder Covid-19 pandemic Cognitive defusion Internet-delivered intervention Mindfulness-based cognitive therapy Self-compassion
Key findings iMBCT produced greater reductions in Adjustment Disorder symptoms than waitlist control and higher remission rates, and compared with iPMR yielded larger decreases in depression and anxiety.

Abstract

Adjustment Disorder (AjD) is a common stress-related condition, yet evidence-based interventions remain scarce. Mindfulness-Based Cognitive Therapy (MBCT) targets transdiagnostic mechanisms such as cognitive fusion and low self-compassion, which may be particularly relevant for AjD. This randomized controlled trial tested the efficacy of a brief, guided, asynchronous internet-delivered MBCT (iMBCT) for AjD during the COVID-19 pandemic, compared with internet-delivered progressive muscle relaxation (iPMR) and a waitlist control (WLC). Adults meeting ICD-11 criteria for AjD (N = 301) were randomized to iMBCT, iPMR, or WLC for four weeks. Primary outcomes were changes in AjD symptoms (ADNM-20) and remission rates. Secondary outcomes were changes in depression, anxiety, cognitive fusion, experiential avoidance, and self-compassion. Outcomes were assessed at baseline, post-intervention, and one-month follow-up. Mediation analyses tested cognitive defusion and self-compassion as mechanisms. iMBCT produced greater reductions in AjD symptoms than WLC (η² =.17) and higher remission rates. Compared with iPMR, iMBCT yielded larger decreases in depression and anxiety. Cognitive defusion fully mediated iMBCT effects on depression and anxiety. Some improvements were maintained at follow-up; however, findings were mixed and should be interpreted cautiously due to substantial attrition. A brief, minimally guided, asynchronous iMBCT is an effective and scalable intervention for AjD that targets cognitive and self-regulatory mechanisms. Findings support the use of online mindfulness-based programs for stress-related disorders during large-scale crises.

Comparable studies

Other randomized controlled trials on meditation, most cited first.

Study Year Design Participants
Alterations in Brain and Immune Function Produced by Mindfulness Meditation Healthy employees in a work environment 2003 Randomized controlled trial n = 41
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Open hearts build lives: Positive emotions, induced through loving-kindness meditation, build consequential personal resources. Working adults 2008 Randomized controlled trial n = 139
Short-term meditation training improves attention and self-regulation Undergraduate Chinese students 2007 Randomized controlled trial n = 40
Mindfulness-Based Cognitive Therapy for Depression: Replication and Exploration of Differential Relapse Prevention Effects. Recovered recurrently depressed patients 2004 Randomized controlled trial n = 73

Citations in the library

Explore topics